S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC)
Natale, R. B., Lara, P. N., Chansky, K., Crowley, J. J., Jett, J. R., Carleton, J. E., Kuebler, J. P., Lenz, H. J., Mack, P. C., Gandara, D. G.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Effects of the 26S proteasome inhibitor, bortezomib, on BCL-2 in small cell lung cancer: Implications for SWOG-0327
Mortenson, M. M., Schlieman, M. G., Virudachalam, S., Lara, P. N., Gandara, D. G., Davies, A. M., Bold, R. J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Effects of the 26S proteasome inhibitor, bortezomib, on BCL-2 in small cell lung cancer: Implications for SWOG-0327
Mortenson, M. M., Schlieman, M. G., Virudachalam, S., Lara, P. N., Gandara, D. G., Davies, A. M., Bold, R. J.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer
Mortenson, Melinda M., Schlieman, Michael G., Virudachalam, Subbulakshmi, Lara, Primo N., Gandara, David G., Davies, Angela M., Bold, Richard J.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2005)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2005)
Get full text
Journal Article